158 related articles for article (PubMed ID: 26541549)
1. Spectrum adequacy of antibiotic regimens for secondary peritonitis: a retrospective analysis in intermediate and intensive care unit patients.
Steinbach CL; Töpper C; Adam T; Kees MG
Ann Clin Microbiol Antimicrob; 2015 Nov; 14():48. PubMed ID: 26541549
[TBL] [Abstract][Full Text] [Related]
2. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
Ramsamy Y; Muckart DJ; Han KS
S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
[TBL] [Abstract][Full Text] [Related]
3. Basis for selecting optimum antibiotic regimens for secondary peritonitis.
Maseda E; Gimenez MJ; Gilsanz F; Aguilar L
Expert Rev Anti Infect Ther; 2016; 14(1):109-24. PubMed ID: 26568097
[TBL] [Abstract][Full Text] [Related]
4. Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation.
Eagye KJ; Kuti JL; Dowzicky M; Nicolau DP
Clin Ther; 2007 May; 29(5):889-899. PubMed ID: 17697907
[TBL] [Abstract][Full Text] [Related]
5. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients.
Li YT; Yu CB; Huang JR; Qin ZJ; Li LJ
World J Gastroenterol; 2015 Sep; 21(36):10409-17. PubMed ID: 26420967
[TBL] [Abstract][Full Text] [Related]
6. Rapid adaptation of antibiotic therapy for community-acquired peritonitis using direct cultures on antibiotic agar plates: pilot study.
Lasocki S; Skurnik D; Muller-Serieys C; Bronchard R; Marcel C; Marmuse JP; Montravers P; Andremont A
Surg Infect (Larchmt); 2009 Aug; 10(4):333-8. PubMed ID: 19622030
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
Sader HS; Farrell DJ; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):443-8. PubMed ID: 24492025
[TBL] [Abstract][Full Text] [Related]
8. Antifungal therapy did not improve outcomes including 30-day all-cause mortality in patients suffering community-acquired perforated peptic ulcer-associated peritonitis with Candida species isolated from their peritoneal fluid.
Li WS; Lee CH; Liu JW
J Microbiol Immunol Infect; 2017 Jun; 50(3):370-376. PubMed ID: 26321461
[TBL] [Abstract][Full Text] [Related]
9. [Bacteriological profile and antibiotic treatment of postoperative peritonitis].
Missaoui K; Marzougui Y; Kouka J; Dhibi Y; Hannachi Z; Dziri C; Houissa M
Arch Inst Pasteur Tunis; 2014; 91(1-4):57-66. PubMed ID: 26485771
[TBL] [Abstract][Full Text] [Related]
10. Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
Solomkin JS; Yellin AE; Rotstein OD; Christou NV; Dellinger EP; Tellado JM; Malafaia O; Fernandez A; Choe KA; Carides A; Satishchandran V; Teppler H;
Ann Surg; 2003 Feb; 237(2):235-45. PubMed ID: 12560782
[TBL] [Abstract][Full Text] [Related]
11. First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage.
Novovic S; Semb S; Olsen H; Moser C; Knudsen JD; Homann C
Scand J Gastroenterol; 2012 Feb; 47(2):212-6. PubMed ID: 22191479
[TBL] [Abstract][Full Text] [Related]
12. [A contemporary situation in the antimicrobial treatment of the secondary peritonitis].
Vyhnánek F; Vranková J
Rozhl Chir; 2005 Sep; 84(9):466-71. PubMed ID: 16250620
[TBL] [Abstract][Full Text] [Related]
13. Critical issues in the clinical management of complicated intra-abdominal infections.
Blot S; De Waele JJ
Drugs; 2005; 65(12):1611-20. PubMed ID: 16060697
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
Rhomberg PR; Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
16. Microbiological profile of patients treated for postoperative peritonitis: temporal trends 1999-2019.
Montravers P; Grall N; Kantor E; Augustin P; Boussion K; Zappella N
World J Emerg Surg; 2023 Dec; 18(1):58. PubMed ID: 38115142
[TBL] [Abstract][Full Text] [Related]
17. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria.
Heizmann WR; Löschmann PA; Eckmann C; von Eiff C; Bodmann KF; Petrik C
Infection; 2015 Feb; 43(1):37-43. PubMed ID: 25367409
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic therapy for abdominal infection.
Bohnen JM
World J Surg; 1998 Feb; 22(2):152-7. PubMed ID: 9451930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
